Ferric Carboxymaltose Injection 50 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL
Reference Brands: Injectafer
Category: Anemia
Ferric Carboxymaltose Injection (Injectafer®/Ferinject®) is an intravenous iron therapy for treating iron deficiency anemia. With a concentration of 50 mg/mL, it allows for large, single-dose infusions. It is widely used in hospitals and clinics across the U.S. and EU.
Product Description:
Ferric Carboxymaltose Injection (brand names Injectafer® in the U.S. and Ferinject® in the EU) is a high-concentration intravenous iron therapy used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron or need rapid iron repletion. With a strength of 50 mg/mL, it allows for large, single-dose infusions, enhancing patient convenience and adherence. In the U.S. and EU, Ferric Carboxymaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In the pharmaceutical B2B sector, it is supplied by licensed manufacturers, contract partners, and distributors to meet institutional needs and ensure global availability.
Ferric Carboxymaltose Injection — third party manufacturing & bulk supply
Ferric Carboxymaltose Injection 50 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ferric Carboxymaltose Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ferric Carboxymaltose Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ferric Carboxymaltose Injection →Frequently Asked Questions
Ferric Carboxymaltose is used to treat iron-deficiency anaemia in patients who cannot tolerate oral iron or need rapid replenishment of iron stores. It helps restore haemoglobin levels and improves symptoms related to low iron.
It is made from a stable iron–carbohydrate complex containing ferric hydroxide tightly bound to a carboxymaltose polymer. This structure allows controlled iron release and efficient absorption.
The main trade name is Injectafer in the US and Ferinject in many international markets.
It is manufactured by Vifor Pharma, and marketed in collaboration with other licensed partners in different countries.
The generic name is Ferric Carboxymaltose.
Brand names include Injectafer and Ferinject.
It is manufactured in multiple Vifor Pharma facilities and approved partner manufacturing sites across Europe and other regions.
Related Products
Ferric Derisomaltose Generics
Strength:
100 mg/ml
Form: IV Infusion
Reference Brands: Monoferric® (U.S.) and Monofer® (EU))
View Details
Elemental Iron, Multivitamin Capsule
Strength:
Elemental Iron: 14 mg - 65 mg
Form: Capsule
Reference Brands: Slow Fe®, Feosol® Complete, Ferrochel®, Irontab®, Feroglobin®, Feroglobin®, SiderAL®
View Details
Crizanlizumab
Strength:
100 mg/10 mL (10 mg/mL)
Form: IV Infusion
Reference Brands: Adakveo®(EU & US)
View Details
Luspatercept,
Strength:
25 mg, 75 mg
Form: Lyophilized powder for subcutaneous injection
Reference Brands: Reblozyl
View Details
Ferrous Fumarate
Strength:
200 mg, 325 mg
Form: Tablets
Reference Brands: Ferro-Fer®, Ferrograd®
View Details
Ferrous Sulfate
Strength:
300mg
Form: Tablet
Reference Brands: Ferro-Gluconate®, Fergon
View Details
Polysaccharide-Iron Complex
Strength:
150 mg
Form: Capsules
Reference Brands: Niferex, Ferrex 150, Ferrousal
View Details
Quick Response Guaranteed | Verified Suppliers
